Dr. Makary argues for more humility from the medical establishment and common sense when reviewing experimental drugs for ...
At the recent CBER agency workshop on cell therapies and tissue-based products, a few surprising ideas discussed could have ...
The FDA’s Oncologic Drugs Advisory Committee recently voted to narrow the label for checkpoint inhibitors Keytruda and Opdivo in stomach and esophageal cancers based on PD-L1 expression levels—but the ...
KFF Health News on MSN1h
How the FDA Lets Chemicals Pour Into America’s Food SupplyThe FDA has relied on food companies for decades to determine whether their ingredients are safe. Some chemicals and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback